Alerts will be sent to your verified email
Verify Email
SHAMROIN
|
Shamrock Indl. Co
|
Beryl Drugs
|
Rekvina Labs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-8.66 % | 3.64 % | -118.34 % |
|
5yr average Equity Multiplier
|
1.02 | 2.12 | 6.31 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 1.19 | 0.0 |
|
5yr Avg Net Profit Margin
|
0.0 | 1.13 % | 0.0 |
|
Price to Book
|
9.39 | 1.16 | 0.0 |
|
P/E
|
0.0 | 47.55 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | -589.78 Days | 0.0 |
|
Inventory Days
|
0.0 | 36.09 Days | 0.0 |
|
Days Receivable
|
0.0 | 112.55 Days | 0.0 |
|
Days Payable
|
0.0 | 964.25 Days | 0.0 |
|
5yr Average Interest Coverage Ratio
|
0.0 | 1.91 | -132.32 |
|
5yr Avg ROCE
|
-8.65 % | 7.2 % | -100.9 % |
|
5yr Avg Operating Profit Margin
|
0.0 | 6.72 % | 0.0 |
|
5 yr average Debt to Equity
|
0.0 | 0.59 | -0.19 |
|
5yr CAGR Net Profit
|
-15.95 % | 19.3 % | 18.47 % |
|
5yr Average Return on Assets
|
-8.47 % | 1.98 % | -132.46 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
43.36 % | 26.38 % | 41.3 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.38 % | 1.46 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Shamrock Indl. Co
|
Beryl Drugs
|
Rekvina Labs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|